Secure-IC's Securyzr™ Fully Digital Physically Unclonable Function (PUF) - PQC Ready
8 Predictions for 2016
Rick Merritt, SiliconValley Bureau Chief
EETimes (12/30/2015 09:58 AM EST)
It's been a long, busy year and my crystal ball is flashing me warnings that its battery is almost spent, so take these few blurry visions for what they're worth.
There will be big layoffs in 2016. OK, that’s an easy one. Avago has a slash-and-burn reputation for how it handled LSI and other acquisitions. I predict the new Broadcom will be a leaner, meaner machine.
Avago/Broadcom was just one of the many, many M&A deals of 2015 that will offer Wall Street a burnt sacrifice of “synergies” in the coming year in the pursuit of bigger profits. Expect an ongoing body count as the electronics industry settles into its golden years single-digit growth.
|
|
E-mail This Article |
|
Printer-Friendly Page |
Related News
- M31 earned NT$12.16 per share in 2022 and approved dividend of NT$8 in cash and NT$1 equivalent in stock
- Qualinx Raises €8 Million to Bring Game-Changing Digital RF Technology to Market
- Sondrel warns that packaging lead time have dramatically increased from 8 to more than 50 weeks
- 2022 to Mark the Third Year in a Row of ≥20% Growth for the Foundry Market
- Faraday Reports 2021 Revenue at NT$8,085 Million, the Second-Best Record
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- Ceva, Inc. Announces First Quarter 2025 Financial Results
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design






